Evidence map›Paper›PMID 41495372›Full record

ArticleZeitschrift fur Rheumatologie2026

Lung-only involvement in STING-associated vasculopathy with onset in infancy: a diagnostic pitfall in the absence of cutaneous vasculitis.

Rabia Miray Kisla Ekinci, Ummuhan Cay, Deniz Kor, Hasan Ali Telefon, Faruk Ekinci, Ozden Ozgur Horoz, Dincer Yildizdas

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Zeitschrift fur Rheumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rabia Miray Kisla EkinciDepartment of Pediatric Rheumatology, Cukurova University Faculty of Medicine, 01331, Adana, Turkey. mir_kisla@hotmail.com.ORCID http://orcid.org/0000-0001-6234-822X
Ummuhan CayDepartment of Pediatric Infectious Diseases, Cukurova University Faculty of Medicine, Adana, Turkey.
Deniz KorDepartment of Pediatric Metabolism, Cukurova University Faculty of Medicine, Adana, Turkey.
Hasan Ali TelefonDepartment of Pediatric Intensive Care, Cukurova University Faculty of Medicine, Adana, Turkey.
Faruk EkinciDepartment of Pediatric Intensive Care, Cukurova University Faculty of Medicine, Adana, Turkey.
Ozden Ozgur HorozDepartment of Pediatric Intensive Care, Cukurova University Faculty of Medicine, Adana, Turkey.
Dincer YildizdasDepartment of Pediatric Intensive Care, Cukurova University Faculty of Medicine, Adana, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSTING-associated vasculopathy with onset in infancy (SAVI) is a rare monogenic autoinflammatory disorder. It is characterized by excessive interferon activity due to gain-of-function mutations in the STING1 gene, resulting in skin lesions and lung involvement. Some patients may also present with interstitial lung disease (ILD) only. While treatment with JAK inhibitors like baricitinib has shown some promise, long-term success is limited. CASE PRESENTATION: We report on a 10-month-old male suffering from respiratory distress since birth. He demonstrated failure to thrive and progressive ILD. The patient lacked skin lesions, arthritis, hepatosplenomegaly, lymphadenopathy, and any clues indicating vasculitis. Erythroid sedimentation rate was normal, and C‑reactive protein (CRP) was slightly elevated. However, CRP became elevated to 115 mg/L during the course of disease. Despite antibiotics and steroids, his condition deteriorated. Chest imaging revealed features suggestive of ILD, prompting further investigation. Whole-exome sequencing confirmed a heterozygotic c.461A > G (p.Asn154Ser) variant in the STING1 gene, thereby diagnosing the patient with SAVI. Despite treatment with baricitinib and tocilizumab, his condition worsened, and he ultimately passed away.

conclusionThis case highlights that SAVI should be considered in the differential diagnosis of ILD, even without typical skin lesions.

Indexed as

Hereditary Autoinflammatory DiseasesLung Diseases, InterstitialMembrane ProteinsVasculitisAzetidinesDiagnosis, DifferentialHumansInfantMalePurinesPyrazolesSTING ProteinSulfonamidesAzetidinesbaricitinibMembrane ProteinsPurinesPyrazolesSTING1 protein, humanSTING ProteinSulfonamidesAutoinflammatory diseaseBaricitinibCase reportChildInterstitial lung disease

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.